Statistics about Health, Pharma & Medtech in Worldwide
Statistics
- Teva Pharmaceutical Industries' total assets 2011-2023
- Teva Pharmaceutical Industries' specialty medicines revenues breakdown 2018-2023
- IQVIA total assets 2013-2023
- Teva Pharmaceutical Industries' legal settlements 2014-2023
- Amgen's property, plant and equipment 2022-2023
- Amgen - dividends paid 2011-2023
- Sales of Johnson & Johnson's consumer healthcare segment by franchise 2014-2022
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Sales of Johnson & Johnson 2006-2023 by region
- Johnson & Johnson's number of employees 2004-2023
- Johnson & Johnson's net earnings 2005-2023
- IQVIA total revenues 2013-2023
- SG&A expenses of IQVIA 2013-2023
- Net income attributable to IQVIA 2013-2023
- IQVIA capital expenditures from 2013-2023
- Merck & Co.'s net income 2006-2023
- Merck & Co number common outstanding shares 2009-2023
- Bristol-Myers Squibb's employee number 2015-2023
- GSK: expenditure on research and development 2006-2023
- Net income per share of Jazz Pharmaceuticals 2016-2023
- Jazz Pharmaceuticals sales in 2021-2023, by therapy area
- Total revenue of Jazz Pharmaceuticals 2018-2023, by region
- Share of net sales to Viatris' largest customers 2018-2023
- Viatris' total revenues 2016-2023
- Viatris' research and development expenses 2016-2023
- Viatris' net earnings 2016-2023
- Viatris' total assets 2016-2023
- Viatris' net sales 2021-2023 by market
- Viatris' EBITDA 2018-2023
- Viatris' net sales in 2023, by business segments
- GSK's profit 2006-2023
- Jazz Pharmaceuticals R&D expenditure 2016-2023
- GSK's revenue 2006-2023
- GSK: cash flow 2006-2023
- GSK's revenue by region 2013-2023
- GSK's revenue by division 2006-2023
- GSK's operating profit by division 2006-2021
- GSK's advertising spending 2011-2023
- LabCorp SG&A expenses 2019-2023
- LabCorp SG&A expenses as percentage of revenues 2019-2023
- Percentage of Elanco revenue by region 2019-2023
- Elanco Animal Health revenue by product category 2017-2023
- Percentage of Elanco revenue by product category 2020-2023
- Net income of Jazz Pharmaceuticals 2016-2023
- Total assets of Jazz Pharmaceuticals 2016-2023
- Sanofi's net income 2007-2023
- Eli Lilly's R&D expenditure as a share of revenue 2010-2023
- Sanofi leading pharmaceutical products 2022-2023
- Sanofi - revenue by segment 2014-2023
- Average number of outstanding shares of Sanofi 2009-2023
- Basic earnings per share of Sanofi 2009-2023
- Sanofi's total assets 2007-2023
- Sanofi revenue by region 2023
- Boston Scientific's net sales by region 2016-2023
- Boston Scientific's net sales 2021-2023 by business
- Eli Lilly's total revenue by segment 2022-2023
- Eli Lilly's total revenue by region 2021-2023
- Eli Lilly's research and development expenditure 2007-2023
- Eli Lilly's net income 2007-2023
- Total revenue of Jazz Pharmaceuticals 2016-2023
- Eli Lilly: marketing expenses 2013-2023
- Eli Lilly total assets 2013-2023
- Eli Lilly capital expenditures 2013-2023
- Eli Lilly income before income taxes 2013-2023
- Eli Lilly employment numbers 2013-2023
- Bayer Group's sales 1995-2023
- Bayer AG's total dividend payment 1999-2023
- Bayer HealthCare's revenue 2005-2018
- Distribution of Bayer Group's net sales 2021-2023 by segment
- Bayer Group's operating numbers 2007-2023
- Number of IQVIA employees worldwide 2014-2023
- Employees at Jazz Pharmaceuticals 2021-2023, by region
- Largest M&A pharmaceutical deals ever as of 2024
- Bristol-Myers Squibb's EBIT 2015-2023
- Elanco Animal Health net income 2015-2023
- Top pharmaceutical companies in R&D spending growth 2022
- Industry revenue of “manufacture of basic pharmaceutical products“ in Italy 2012-2025
- Industry revenue of “manufacture of basic pharmaceutical products“ in Switzerland 2012-2025
- Industry revenue of “manufacture of basic pharmaceutical products“ in Belgium 2012-2025
- Industry revenue of “manufacture of basic pharmaceutical products“ in Spain 2012-2025
- Industry revenue of “manufacture of basic pharmaceutical products“ in the United Kingdom 2012-2025
- Industry revenue of “manufacture of basic pharmaceutical products“ in Cyprus 2012-2025
- Industry revenue of “manufacture of basic pharmaceutical products“ in Sweden 2012-2025
- Pfizer - cash dividends paid 2006-2023
- Industry revenue of “manufacture of basic pharmaceutical products“ in Finland 2012-2025
- Number of antibiotics in clinical pipeline targeting WHO pathogens by type 2021
- Life sciences' leading M&A deals worldwide H1 2018
- Top pharma and biotech companies by net sales growth in 2022
- Industry revenue of “manufacture of basic pharmaceutical products“ in Greece 2012-2025
- Top 50 global pharmaceutical and biotech companies by R&D intensity in 2022
- Industry revenue of “manufacture of basic pharmaceutical products“ in Poland 2012-2025
- Top pharmaceutical and biotech companies by profit growth in 2022
- Changes in outpatient prescriptions in Daegu and Gyeongbuk South Korea 2020
- Changes in outpatient prescriptions during COVID-19 in Seoul South Korea 2020
- Changes in outpatient prescriptions in Daejeon and Chungcheong South Korea 2020
- Impact of COVID-19 on revenue of hospitality and retail sector South Korea 2020
- Adjusted pharmaceutical sales forecast in South Korea 2020, by drug type
- World's most valuable pharmaceutical brands 2023 by brand value
- Distribution of total funding on R&D for selected diseases 2020-2022
- Funding for research and development on HIV/AIDS 2020-2022, by area